en · de · es · fr · pt
selank-notes.peptides6088.com › Wiki › Administration, Testing And Availability — Practical Notes

Administration, Testing And Availability — Practical Notes

By Editorial Desk · published 2025-10-27 · last reviewed 2025-11-11 · Wiki

A practical reference on Semax: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-11-11. Anything still debated is marked as such rather than presented as settled.

Administration, Testing and Availability

Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.

Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.

Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.

Background and Molecular Identity

Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.

Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.

Selank at a glance

PropertyValueNotes
Common routeIntranasalAlso injected in some animal work
Solubility classFreely soluble in waterSolid form is hygroscopic
Typical storageAbout -20 degrees CelsiusKeep desiccated and dark
Purity methodReverse-phase HPLCReported as area percent
Confirmatory methodMass spectrometryVerifies expected molecular mass

Selank Origin and Chemical Identity

Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.

Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.

Related pages on this site

Identity and Structural Background

Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.

Notes from published material

== History == The NAFBL was formed in January 1895 and in March 1895, the NAFBL began operation as the third significant U.S. soccer league. It drew its teams primarily from northern New Jersey and New York City. Few records exist for the league, but the teams and standings for four of the five seasons do exist. After its first spring-summer season in 1895, the NAFBL moved to a winter schedule in the fall of 1895. On December 16, 1895, the NAFBL opened its second season with a game pitting the Kearny Scottish-Americans and the International Athletic Club. In 1899, a deep recession, accompanied by the Spanish–American War led to the collapse of several athletic leagues and teams, among them the NAFBL. On August 14, 1906, the league was revived and continued in operation until 1921. That year, several of the top NAFBL teams, frustrated by the amateur/semi-professional nature of the league, joined with other top North Atlantic U.S. teams to form the first fully professional U.S. soccer league, the American Soccer League.

2 parts bai zhi (Chinese:白芷,Angelica dahurica); 2 parts cao wu (Chinese:草烏,Aconitum sp., monkshood or wolfsbane); 2 parts chuān ban xia (Pinellia ternata); 2 parts chuān xiōng (Ligusticum wallichii, Cnidium rhizome, Cnidium officinale or Szechuan lovage); 2 parts dong quai (Angelica sinensis or female ginseng); 1 part tian nan xing (Arisaema rhizomatum or cobra lily) 8 parts yang jin hua (Datura stramonium, Korean morning glory, thorn apple, jimson weed, devil's trumpet, stinkweed, or locoweed). The active ingredients in tsūsensan are scopolamine, hyoscyamine, atropine, aconitine and angelicotoxin. When consumed in sufficient quantity, tsūsensan produces a state of general anesthesia and skeletal muscle paralysis. Shutei Nakagawa (1773–1850), a close friend of Hanaoka, wrote a small pamphlet titled "Mayaku-ko" ("narcotic powder") in 1796. Although the original manuscript was lost in a fire in 1867, this brochure described the current state of Hanaoka's research on general anesthesia. On 13 October 1804, Hanaoka performed a partial mastectomy for breast cancer on a 60-year-old woman named Kan Aiya, using tsūsensan as a general anaesthetic. This is generally regarded today as the first reliable documentation of an operation to be performed under general anesthesia. Hanaoka went on to perform many operations using tsūsensan, including resection of malignant tumors, extraction of bladder stones, and extremity amputations. Before his death in 1835, Hanaoka performed more than 150 operations for breast cancer.

X-ray diffraction studies of microcrystals revealed atomistic details of core region of amyloid, although only for simplified peptides having a length remarkably shorter than that of peptides or proteins involved in disease. The crystallographic structures show that short stretches from amyloid-prone regions of amyloidogenic proteins run perpendicular to the filament axis, consistent with the "cross-β" feature of amyloid structure. They also reveal a number of characteristics of amyloid structures – neighboring β-sheets are tightly packed together via an interface devoid of water (therefore referred to as dry interface), with the opposing β-strands slightly offset from each other such that their side-chains interdigitate. This compact dehydrated interface created was termed a steric-zipper interface. There are eight theoretical classes of steric-zipper interfaces, dictated by the directionality of the β-sheets (parallel and anti-parallel) and symmetry between adjacent β-sheets. A limitation of X-ray crystallography for solving amyloid structure is represented by the need to form microcrystals, which can be achieved only with peptides shorter than those associated with disease. Although bona fide amyloid structures always are based on intermolecular β-sheets, different types of "higher order" tertiary folds have been observed or proposed. The β-sheets may form a β-sandwich, or a β-solenoid which may be either β-helix or β-roll. Native-like amyloid fibrils in which native β-sheet containing proteins maintain their native-like structure in the fibrils have also been proposed.

The adoption of -gate to suggest the existence of a scandal was promoted by William Safire, the conservative New York Times columnist and former Nixon administration speechwriter. As early as September 1974, he wrote of "Vietgate", a proposed pardon of the Watergate criminals and Vietnam War draft dodgers. Subsequently, he coined numerous -gate terms, including Billygate, Briefingate, Contragate, Deavergate, Debategate, Doublebillingsgate (of which he later said "My best [-gate coinage] was the encapsulation of a minor ... scandal as doublebillingsgate"), Frankiegate, Franklingate, Genschergate, Housegate, Iraqgate, Koreagate, Lancegate, Maggiegate, Nannygate, Raidergate, Scalpgate, Travelgate, Troopergate, and Whitewatergate. The New York magazine suggested that his aim in doing so was "rehabilitating Nixon by relentlessly tarring his successors with the same rhetorical brush – diminished guilt by association". Safire himself later said to author Eric Alterman that he "may have been seeking to minimize the relative importance of the crimes committed by his former boss with this silliness". The usage has spread into languages other than English; examples of -gate being used to refer to local political scandals have been reported from Argentina, Germany, South Korea, Hungary, Greece and the former Yugoslavia. The term is also used in Mandarin Chinese with the suffix -mén (simplified Chinese: 门; traditional Chinese: 門; lit. 'door', 'gate'). Some commentators have characterized this use of the -gate suffix as a snowclone.

Sources: en.wikipedia.org

Further detail

=== Notable cases === As of April 2016, six hyperthymesia cases have been confirmed in peer-reviewed articles, the first being that of Jill Price (initially anonymised as "AJ") in 2006. More cases had been identified by 2012, but are yet to be published. Price's case was originally reported by researchers from the University of California, Irvine, Elizabeth Parker, Larry Cahill and James McGaugh, and is credited as being the first documented case of hyperthymesia. Price can apparently recall every day of her life from when she was 14 years old: "Starting on February 5, 1980, I remember everything. That was a Tuesday." In March 2009, Price was interviewed for an article in Wired magazine by Gary Marcus, a cognitive psychologist at New York University. Price's brain had been subject to a brain scan and the hippocampus and prefrontal cortex had been reportedly normal. Marcus claimed, however, that her brain resembled "those of people with obsessive-compulsive disorder" and suggested that her remarkable memory might be "the byproduct of obsession", claiming also that "the memory woman clings tightly to her past". Price strongly disputed this and McGaugh has also challenged the explanation. Price gave her first interview in over a year for the UK's Channel 4 documentary The Boy Who Can't Forget, and spoke of the challenges of living with the condition. K.

1993/1626) Castle Vale Housing Action Trust (Area and Constitution) Order 1993 (S.I. 1993/1634) Gipsy Encampments (Borough of Surrey Heath) Order 1993 (S.I. 1993/1635) Tower Hamlets Housing Action Trust (Area and Constitution) Order 1993 (S.I. 1993/1636) Value Added Tax (General) (Amendment) (No. 5) Regulations 1993 (S.I. 1993/1639) Reconstitution of the Witham First District Internal Drainage Board Order 1993 (S.I. 1993/1640) Import (Plant Health Fees) (England and Wales) Order 1993 (S.I. 1993/1641) Plant Passport (Plant Health Fees) (England and Wales) Regulations 1993 (S.I. 1993/1642) Environmental Protection (Controls on Injurious Substances) (No. 2) Regulations 1993 (S.I. 1993/1643) Alcan Aluminium UK Ltd. (Rateable Values) (Scotland) Order 1993 (S.I. 1993/1644) Forth Ports plc (Rateable Values) (Scotland) Order 1993 (S.I. 1993/1645) Caledonian MacBrayne Limited (Rateable Values) (Scotland) Order 1993 (S.I. 1993/1646) Tunbridge Wells and Eridge Light Railway Order 1993 (S.I. 1993/1651) Asylum and Immigration Appeals Act 1993 (Commencement and Transitional Provisions) Order 1993 (S.I. 1993/1655) Immigration (Restricted Right of Appeal against Deportation) (Exemption) Order 1993 (S.I. 1993/1656) Immigration (Variation of Leave) (Amendment) Order 1993 (S.I. 1993/1657) Extraction Solvents in Food Regulations 1993 (S.I. 1993/1658) Education (Assisted Places) (Scotland) Amendment Regulations 1993 (S.I. 1993/1659) St Mary's Music School (Aided Places) Amendment Regulations 1993 (S.I. 1993/1660) Asylum Appeals (Procedure) Rules 1993 (S.I.

=== Mechanism of action === Melarsoprol is a prodrug, a complex of melarsen oxide (a melamine derivative of phenylarsonous acid) with dimercaprol (also known as British anti-Lewisite, or BAL). It is metabolized to melarsen oxide in the body, which then forms a toxic compound known as Mel T, through binding with trypanothione, (a spermidine-glutathione adduct that replaces glutathione in trypanosomes). While Mel T is a competitive inhibitor of trypanothione reductase, research suggests this is not sufficient to explain the rapid cell death of the trypanosome parasites. Some research has also discredited the theory that the disruption of glycolysis is essential to its mechanism of action. While the exact mechanism of action of melarsoprol has not been determined beyond the formation of Mel T, it has been suggested that this complex is implicated in several cytotoxic processes, including inhibition of DNA synthesis and increasing susceptibility to oxidative stress. This follows from the fact that trypanothione itself plays a role in the proper function of a variety of biochemical pathways.

=== Active site === Comparisons between bacterial, archaeal and eukaryotic ribosome structures reveal a very high degree of conservation in the active site region — the peptidyl transferase center (PTC). None of the eukaryote-specific protein elements is close enough to directly participate in catalysis. However, RPL29 projects to within 18Å of the active site in T. thermophila, and eukaryote-specific extensions interlink several proteins in the vicinity of the PTC of the 60S subunit, while the corresponding 50S proteins are singular entities.

=== First term (2018–2019) === Talarico launched his campaign for the Texas House shortly after incumbent state legislator Larry Gonzales chose not to run for reelection. He won the concurrent special and general elections against Republican nominee Cynthia Flores, garnering media attention for walking the full length of the district. He was sworn into the Texas House of Representatives on November 20, 2018, and appointed to the Public Education and Juvenile Justice Committees. In the 86th Texas Legislature, Talarico filed the Whole Student Agenda, a 24-bill public education policy legislative package. The legislature passed two bills from this list. The first, HB 3012, required that students suspended from school have an alternative means to receive coursework. HB 455, also sponsored by Talarico, was written to provide a standardized school recess policy. Governor Greg Abbott vetoed the bill.

Sources: en.wikipedia.org

Frequently asked questions

How is the peptide typically administered in studies?

Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.

What do the human studies show?

Reported human trials are few, brief and originate mainly from one country. They describe effects on anxiety-related measures, but sample sizes are small and reporting is limited. The results are widely regarded as preliminary rather than confirmed.

How is sample identity verified?

Reverse-phase liquid chromatography is used to assess purity and separation of related impurities. Mass spectrometry confirms that the observed molecular mass matches the expected peptide. A certificate of analysis from the supplier is the usual document of record.

What is Selank chemically?

Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.

Network